Future cell and molecular biology studies are required to determine the underlying mechanisms of TWEAK regarding its effects on quadriceps muscle atrophy, fiber-type alteration and the expression of MuRF1, NF-κB and PGC-1α, with the latter also requiring confirmation in patients with COPD. The gene discussed is TRIM63; the disease is chronic obstructive pulmonary disease.